ClinicalTrials.gg
RecruitingNCT07899931Updated Oct 28, 2026

Vision-Language-Based Large-Scale Model for Emergency Screening

An interventional study of powER vision-language large-model assisted CT reading and Conventional CT reading without AI assistance in Acute Thoraco-Abdominal Emergency Lesions, sponsored by The First Hospital of Jilin University. Recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-28.

Sponsored by The First Hospital of Jilin University · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.
Updated Oct 28, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
640
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This is a single-center, prospective, stratified 1:1 parallel-group randomized superiority diagnostic trial at The First Hospital of Jilin University. Eligible emergency patients aged ≥18 who received routine thoraco-abdominal non-contrast CT were randomly assigned to two groups. The experimental group adopted a self-developed vision-language large model (powER) for auxiliary CT interpretation, while the control group received standard radiological reading without AI assistance. All participants completed standardized 60-day clinical follow-up to obtain clinical gold-standard outcomes. The primary objective is to compare the diagnostic performance of the AI model versus conventional radiology interpretation for multiple acute thoraco-abdominal emergency lesions.

Read the detailed description

This single-center prospective randomized controlled trial adopted a parallel-group superiority design with a 1:1 allocation ratio. Randomization was performed via an independent central randomization system without stratification to avoid allocation bias. The trial is open-label for radiologists performing image interpretation, while outcome adjudicators and biostatisticians remain blinded to group assignment throughout analysis. Two study arms were set:

Experimental Arm: Radiologists interpreted thoraco-abdominal CT scans assisted by the powER vision-language foundation model. The model performs inference on input CT images and outputs ranked top 3 suspected critical lesions covering 18 categories of acute thoracic and abdominal emergencies, including aortic dissection, visceral lacerations, multiple fractures, acute pancreatitis, intestinal obstruction, etc.

Control Arm: The powER model also runs full background AI inference for every case and stores model outputs in the backend database, but no AI-generated lesion findings are displayed to the reading radiologists. Radiologists perform CT diagnosis on native PACS workstations relying solely on conventional clinical experience, with identical web interfaces as the experimental arm.

All eligible patients presented emergency-related clinical indications for thoraco-abdominal CT, with image quality meeting diagnostic standards. Pregnant women, patients with uncorrectable severe imaging artifacts, and those receiving only head or limb CT were excluded. All patient imaging and clinical data were fully de-identified for privacy protection.

The primary outcome measure was diagnostic decision-making time per case, defined as the time interval from the reporting radiologist opening the case on the web platform to the submission of diagnostic selections for target emergency lesions.

Secondary outcome measures included the ROC-AUC, sensitivity, specificity, PPV and NPV of lesion identification by reporting radiologists (using integrated clinical diagnosis, surgery and pathological results within 60-day follow-up as the reference gold standard), total report-writing turnaround time, report review turnaround time, radiologist diagnostic confidence score, and diagnostic consistency between reporting radiologists and the clinical reference standard (Kappa value).

Exploratory endpoints covered subgroup performance stratified by disease severity, identification capacity for rare emergency lesions, and auxiliary effects on radiologists with different seniority levels.

All participants signed written informed consent before enrollment. Standardized 60-day follow-up was implemented to record hospitalization duration, complications and all-cause 60-day mortality. Adverse events related to AI misdiagnosis or system failure were fully recorded and reported to the institutional ethics committee. All statistical analyses followed pre-specified statistical plans. The between-group comparison of the primary continuous time endpoint will use t-test or Mann-Whitney U test as appropriate. The DeLong test will be adopted for AUC comparison of secondary diagnostic outcomes, and mixed-effect regression models will be used for further adjusted analyses. The total planned enrollment will be determined based on the sample size calculation for the primary outcome of diagnostic decision-making time.

02

Conditions studied

  • Acute Thoraco-Abdominal Emergency Lesions

Keywords

  • Artificial intelligence
  • Large language model
  • Emergency CT
  • Thoraco-abdominal diseases
  • Diagnostic performance
03

In context

Lead sponsor

The First Hospital of Jilin University is the lead sponsor of 185 studies on the registry; 96 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients aged 18 years or older presenting to emergency department requiring thoraco-abdominal CT examination for suspected acute intra-thoracic or intra-abdominal emergency conditions.
  • Clinically indicated emergency thoraco-abdominal CT scan ordered by emergency physicians.
  • Patient or legal representative provides written for participation in this prospective study.
  • Availability for clinical follow-up to establish reference-standard diagnosis.

Exclusion criteria

Exclusion Criteria:

  • Age under 18 years old.
  • for contrast-enhanced CT examination (severe contrast allergy, uncorrectable severe renal dysfunction).
  • Inability to complete CT acquisition according to protocol due to critical clinical instability.
  • Refusal to participate or inability to obtain valid .
  • Prisoners or vulnerable populations who are inappropriate for enrollment.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
640 participants (estimated)

Study arms

  • Experimental
    powER vision-language large-model assisted CT reading

    Radiologists interpret emergency thoraco-abdominal CT scans with auxiliary outputs generated by the powER vision-language large model. This AI system identifies suspected critical lesions and presents these findings as references to support radiological review. Radiologists retain the final diagnostic decision. All participants receive routine standard clinical management.

    Diagnostic Test: powER vision-language large-model assisted CT reading

  • Active comparator
    Conventional CT reading without AI assistance

    Radiologists perform independent reading of emergency thoraco-abdominal CT on standard PACS workstation, without any AI auxiliary tools. Diagnosis relies solely on radiologists' conventional clinical experience.

    Diagnostic Test: Conventional CT reading without AI assistance

Interventions

  • Diagnostic testpowER vision-language large-model assisted CT reading

    Standard manual interpretation of emergency thoraco-abdominal CT by radiologists with AI model assistance.

  • Diagnostic testConventional CT reading without AI assistance

    Standard manual interpretation of emergency thoraco-abdominal CT by radiologists without AI model assistance.

06

What researchers measure

Primary outcomes

  1. Per-case CT diagnostic decision time

    Time interval from opening the emergency thoraco-abdominal CT case on the reading platform to completion of critical lesion selection for diagnostic decision-making. This outcome compares the powER vision-language large-model assisted reading group with the conventional radiological reading group.

    Time frame: Day 1 (at completion of CT image reading)

Secondary outcomes

  1. Sensitivity for detecting critical emergency lesions on emergency thoraco-abdominal CT

    Sensitivity for detection of critical emergency lesions (including hemorrhage, visceral perforation, aortic dissection, etc.) on emergency thoraco-abdominal CT. The 60-day comprehensive clinical, surgical and pathological findings after randomization serve as the reference gold standard. This outcome compares powER vision-language large-model assisted radiological reading with conventional radiological reading.

    Time frame: up to 60 days

Other outcomes

  1. Specificity for detecting critical emergency lesions on emergency thoraco-abdominal CT

    Specificity for detection of critical emergency lesions on emergency thoraco-abdominal CT. The 60-day comprehensive clinical, surgical and pathological findings after randomization serve as the reference gold standard. This outcome compares powER vision-language large-model assisted radiological reading with conventional manual radiological reading.

    Time frame: up to 60 days

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — Individual-participant data will not be shared externally due to patient privacy protection requirements and local data-regulatory constraints. Aggregated study results will be published in peer-reviewed journals.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2026 (actual). Primary completion is estimated for Oct 2026, 1 month after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 15, 2026
First posted
Oct 28, 2026
StartActual
Sep 1, 2026
Primary completionEst.
Oct 31, 2026
CompletionEst.
Nov 10, 2026
Last update
Oct 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 28, 2026
Show all 1 update
  1. Oct 28, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07899931
Responsible party
Sponsor
First posted
Oct 28, 2026
Start date
Sep 1, 2026
Primary completion
Oct 31, 2026 (estimated)
Completion
Nov 10, 2026 (estimated)
Last update
Oct 28, 2026

Study contacts

Jiaqi Gong Gong, MBBS
Contact
1223841862@qq.com
+8615104483768

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion